Indicators of immune status in women with different recurrence rates of nonspecific inflammatory diseases of the genital organs
DOI:
https://doi.org/10.14739/2310-1210.2023.3.269374Keywords:
deficiency IgE, deficiency NKT cells, relapse, immunologic tests, immunodeficiencyAbstract
Non-specific inflammatory diseases of the female genital organs (NIDFGO) are an important problem of modern gynecology due to their high frequency in the population, the tendency to frequent recurrences, and many cases of resistance to recommended antimicrobial and anti-inflammatory drugs.
Aim: to study indicators of immune status in women with different recurrence rates of NIDFGO and biomarkers of recurrences to improve potential therapeutic approaches and prevent recurrences in the further.
Materials and methods. A prospective single-center controlled non-randomized clinical study was conducted with the participation of 98 adult women. Out of them, 80 patients with NIDFGO had one-year recurrence rate of 1, 2–3, 4 or more events, and 18 age-matched women without NIDFGO were assigned to the control group. Immunogram and hemogram were performed for all study participants using standardized methods. Statistical analysis of the results was performed using IBM SPSS 23 statistical package software.
Results. The mean serum concentration of IgE in patients with frequent relapses was 3 times (p < 0.05) lower than that in women with only one recurrence, 2.6 times (p < 0.05) lower than that in patients with medium recurrence rate, and 3.4 times (p < 0.05) less than in the control. In women with frequent recurrences, the mean relative number of blood NKT cells was 3.5 times (p < 0.05) less than that in patients with only one recurrence, 2.3 times (p < 0.05) less than that in persons with medium recurrence rate, and 3 times (p < 0.05) less as compared to women of the control group.
Conclusions. Selective deficiencies of IgE and NKT cells in women with NIDFGO are factors that lead to a higher frequency of disease exacerbations per year. T he development and clinical approval of immunotherapeutic approaches to compensate for deficiencies of IgE and NKT cells in women with NIDFGO will contribute to the imposition of immune control over the inflammatory process, increase the effectiveness of antimicrobial treatment, resulting in a decrease in the recurrence rate.
References
Mohankumar, B., Shandil, R. K., Narayanan, S., & Krishnan, U. M. (2022). Vaginosis: Advances in new therapeutic development and microbiome restoration. Microbial pathogenesis, 168, 105606. https://doi.org/10.1016/j.micpath.2022.105606
Davydenko, K. I., Maltsev, D. V., Batman, Yu. A., & Natrus, L. V. (2022). Vyvchennia imunnykh porushen pry nespetsyfichnykh khronichnykh zapalnykh zakhvoriuvanniakh statevykh orhaniv u zhinok [Study of the immune disorders in nonspecific chronic inflammatory diseases of the genital organs]. Fiziologichnyi Zhurnal, 68(3), 68-77. [in Ukrainian]. https://doi.org/10.15407/fz68.03.068
Pate, M. B., Smith, J. K., Chi, D. S., & Krishnaswamy, G. (2010). Regulation and dysregulation of immunoglobulin E: a molecular and clinical perspective. Clinical and molecular allergy : CMA, 8, 3. https://doi.org/10.1186/1476-7961-8-3
Colas, L., Magnan, A., & Brouard, S. (2022). Immunoglobulin E response in health and disease beyond allergic disorders. Allergy, 77(6), 1700-1718. https://doi.org/10.1111/all.15230
Roco, J. A., Mesin, L., Binder, S. C., Nefzger, C., Gonzalez-Figueroa, P., Canete, P. F., Ellyard, J., Shen, Q., Robert, P. A., Cappello, J., Vohra, H., Zhang, Y., Nowosad, C. R., Schiepers, A., Corcoran, L. M., Toellner, K. M., Polo, J. M., Meyer-Hermann, M., Victora, G. D., & Vinuesa, C. G. (2019). Class-Switch Recombination Occurs Infrequently in Germinal Centers. Immunity, 51(2), 337-350.e7. https://doi.org/10.1016/j.immuni.2019.07.001
Kawakami, T., Kasakura, K., Kawakami, Y., & Ando, T. (2022). Immunoglobulin E-Dependent Activation of Immune Cells in Rhinovirus-Induced Asthma Exacerbation. Frontiers in allergy, 3, 835748. https://doi.org/10.3389/falgy.2022.835748
Lim, J., Lin, E. V., Hong, J. Y., Vaidyanathan, B., Erickson, S. A., Annicelli, C., & Medzhitov, R. (2022). Induction of natural IgE by glucocorticoids. The Journal of experimental medicine, 219(10), e20220903. https://doi.org/10.1084/jem.20220903
Magen, E., Schlesinger, M., David, M., Ben-Zion, I., & Vardy, D. (2014). Selective IgE deficiency, immune dysregulation, and autoimmunity. Allergy and asthma proceedings, 35(2), e27-e33. https://doi.org/10.2500/aap.2014.35.3734
García Pavón Osorio, S., López Tiro, J. J., & Gómez Vera, J. (2009). Deficiencia de IgE: un padecimiento olvidado? [IgE deficiency: a forgotten disease?]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993), 56(6), 192-197.
Starkl, P., Watzenboeck, M. L., Popov, L. M., Zahalka, S., Hladik, A., Lakovits, K., Radhouani, M., Haschemi, A., Marichal, T., Reber, L. L., Gaudenzio, N., Sibilano, R., Stulik, L., Fontaine, F., Mueller, A. C., Amieva, M. R., Galli, S. J., & Knapp, S. (2020). IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcusaureus. Immunity, 53(4), 793-804.e9. https://doi.org/10.1016/j.immuni.2020.08.002
Jakwerth, C. A., Ordovas-Montanes, J., Blank, S., Schmidt-Weber, C. B., & Zissler, U. M. (2022). Role of Respiratory Epithelial Cells in Allergic Diseases. Cells, 11(9), 1387. https://doi.org/10.3390/cells11091387
Correa, F. J. S., Andres, M. P., Rocha, T. P., Carvalho, A. E. Z., Aloia, T. P. A., Corpa, M. V. N., Kallas, E. G., Mangueira, C. L. P., Baracat, E. C., Carvalho, K. I., & Abrão, M. S. (2022). Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis. Clinics (Sao Paulo, Brazil), 77, 100032. https://doi.org/10.1016/j.clinsp.2022.100032
Wen, X., Zhang, X., Nian, S., Wei, G., Guo, X., Yu, H., Xie, X., Ye, Y., & Yuan, Q. (2021). Title of article: Mucosal-associated invariant T cells in lung diseases. International immunopharmacology, 94, 107485. https://doi.org/10.1016/j.intimp.2021.107485
Chung, B. K., Tsai, K., Allan, L. L., Zheng, D. J., Nie, J. C., Biggs, C. M., Hasan, M. R., Kozak, F. K., van den Elzen, P., Priatel, J. J., & Tan, R. (2013). Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood, 122(15), 2600-2608. https://doi.org/10.1182/blood-2013-01-480665
Björkström, N. K., Strunz, B., & Ljunggren, H. G. (2022). Natural killer cells in antiviral immunity. Nature reviews. Immunology, 22(2), 112-123. https://doi.org/10.1038/s41577-021-00558-3
Lang, G. A., Shrestha, B., Amadou Amani, S., Shadid, T. M., Ballard, J. D., & Lang, M. L. (2021). α-Galactosylceramide-Reactive NKT Cells Increase IgG1 Class Switch against a Clostridioides difficile Polysaccharide Antigen and Enhance Immunity against a Live Pathogen Challenge. Infection and immunity, 89(11), e0043821. https://doi.org/10.1128/IAI.00438-21
Nogueira-Neto, J., Loures, F. V., Schanoski, A. S., Andrade, D. A. G., Gonzatti, M. B., Costa, T. A., Vivanco, B. C., Xander, P., Rosa, D. S., Calich, V. L. G., & Keller, A. C. (2021). Invariant Natural Killer T Cells as Key Players in Host Resistance against Paracoccidioides brasiliensis. Journal of immunology research, 2021, 6673722. https://doi.org/10.1155/2021/6673722
Hirai, T., Lin, P. Y., Simonetta, F., Maas-Bauer, K., Turkoz, M., Mavers, M., Baker, J., & Negrin, R. S. (2021). Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD. Blood advances, 5(11), 2528-2538. https://doi.org/10.1182/bloodadvances.2020003272
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)